That is the question seemingly unaddressed in the announcement. Reading between the lines 7 completed more than six months treatment and 2 more than 10 months.
Assuming that the 2 patients are not a subset on the 7, that means it appears 5 of 14 didn’t survive 6 months. If median survival is 5.5 months this suggests the median survival isn’t much longer with use of Amplia’s agent.
Cue the outrage from the true believers.
- Forums
- ASX - By Stock
- Ann: Update on ACCENT Trial in Pancreatic Cancer
That is the question seemingly unaddressed in the announcement....
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.4¢ |
Change
0.001(1.08%) |
Mkt cap ! $33.67M |
Open | High | Low | Value | Volume |
9.1¢ | 10.5¢ | 9.1¢ | $541.5K | 5.481M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 79928 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 556 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 79928 | 0.094 |
2 | 160869 | 0.092 |
3 | 101800 | 0.091 |
5 | 176111 | 0.090 |
2 | 311200 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 556 | 1 |
0.097 | 5 | 1 |
0.098 | 70808 | 4 |
0.100 | 5073590 | 2 |
0.105 | 435197 | 5 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online